VYNE Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	19.35	19.93	30.62	30.91	42.25	57.56
Short-Term Investments	13.35	41.59	62.63	-	-	1.03
Cash & Short-Term Investments	32.7	61.52	93.25	30.91	42.25	58.59
Cash Growth	-53.41%	-34.03%	201.71%	-26.85%	-27.89%	-18.75%
Accounts Receivable	-	-	-	-	7.58	15.82
Other Receivables	-	-	-	5	-	-
Receivables	-	-	-	5	7.58	15.82
Inventory	-	-	-	-	-	7.4
Prepaid Expenses	3.19	2.92	2.66	2.3	4.57	4.59
Restricted Cash	-	-	0.05	0.07	0.61	0.86
Other Current Assets	-	-	-	-	8.18	-
Total Current Assets	35.89	64.44	95.96	38.28	63.19	87.26
Property, Plant & Equipment	0.1	0.21	0.21	-	0.35	2.14
Other Long-Term Assets	0.15	2.26	1.52	2.48	3.51	4.35
Total Assets	36.13	66.91	97.69	40.76	67.05	93.74
Accounts Payable	1.2	2.71	1.66	2.39	6.51	4.78
Accrued Expenses	2.65	8.59	3.51	4.26	6.06	10.32
Current Portion of Leases	-	0.1	0.12	-	0.35	0.76
Current Unearned Revenue	-	-	-	-	-	5.8
Other Current Liabilities	0.2	3.42	2.25	2.7	5.49	0.1
Total Current Liabilities	4.04	14.82	7.54	9.35	18.41	21.77
Long-Term Debt	-	-	-	-	-	33.17
Long-Term Leases	-	-	0.1	-	-	0.85
Other Long-Term Liabilities	-	-	1.31	-	-	0.46
Total Liabilities	4.04	14.82	8.95	9.35	18.41	56.25
Common Stock	0	0	0	-	0.01	0
Additional Paid-In Capital	784.9	783.24	780.04	693.94	688.16	603.69
Retained Earnings	-752.82	-731.17	-691.34	-662.74	-639.53	-566.2
Comprehensive Income & Other	0	0.02	0.03	-	-	-
Total Common Equity	32.09	52.09	88.74	31.2	48.64	37.49
Shareholders' Equity	32.09	52.09	88.74	31.41	48.64	37.49
Total Liabilities & Equity	36.13	66.91	97.69	40.76	67.05	93.74
Total Debt	-	0.1	0.21	-	0.35	34.78
Net Cash (Debt)	32.7	61.42	93.04	30.91	41.9	23.81
Net Cash Growth	-53.33%	-33.99%	201.02%	-26.24%	76.01%	-36.75%
Net Cash Per Share	0.77	1.44	9.06	9.70	14.66	13.22
Filing Date Shares Outstanding	33.04	15.21	14.1	3.26	3.12	2.85
Total Common Shares Outstanding	31.77	14.83	14.1	3.23	2.98	2.4
Working Capital	31.84	49.62	88.43	28.93	44.78	65.49
Book Value Per Share	1.01	3.51	6.29	9.66	16.34	15.62
Tangible Book Value	32.09	52.09	88.74	31.2	48.64	37.49
Tangible Book Value Per Share	1.01	3.51	6.29	9.66	16.34	15.62
Machinery	0.12	0.12	-	-	0.85	0.94
Leasehold Improvements	-	-	-	-	0.06	0.06

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q